Lycopene and beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines

Anticancer Research

Volumn 34, Issue 3, 2014, Pages 1377-1386

  Gloria, Nathalie Fonseca ^a   Soares, Nathalia ^b   Brand, Camila ^b   Oliveira, Felipe Leite ^b   Borojevic, Radovan ^c   Teodoro, Anderson Junger ^a  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Section of Urology   (Brazil)

Author keywords

Beta carotene; Bioactive compounds; Breast cancer; Cell cycle; Lycopene

Indexed keywords

BETA CAROTENE; LYCOPENE; ANTINEOPLASTIC AGENT; CAROTENOID; VITAMIN;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ADENOCARCINOMA; BIOACTIVE COMPOUNDS; BREAST CANCER; BREAST TUMOR; CELL CYCLE; CELL CYCLE CHECKPOINT; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BETA-CAROTENE; BIOACTIVE COMPOUNDS; BREAST CANCER; CELL CYCLE; LYCOPENE;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; APOPTOSIS; BETA CAROTENE; BLOTTING, WESTERN; BREAST NEOPLASMS; CAROTENOIDS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; TUMOR CELLS, CULTURED; VITAMINS;

EID: 84899696166     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Simmonds MA: Cancer statistics, 2003: Further decrease in mortality rate, increase in persons living with cancer. Cancer J Clin 53(1): 4, 2003.
2. Silvera SA, Jain M, Howe GR, Miller AB and Rohan TE: Energy balance and breast cancer risk: A prospective cohort study. Breast Cancer Res Treat 97(1): 97-106, 2006.
3. Barrett-Connor E and Friedlander NJ: Dietary fat, calories, and the risk of breast cancer in postmenopausal women: A prospective population-based study. J Am Coll Nutr 12(4): 390-399, 1993.
4. Kim L, Rao V and Rao L: Effects of lycopene on prostate LNCaP cancer cells in culture. J Med Food 5(4): 181-187, 2002.
5. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K and Nagao A: Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131(12): 3303-3306, 2001.
6. Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N and Stephenson Jr HE: Relationship of serum carotenoids, retinal, alpha-tocopherol and selenium with breast cancer risk:results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 9(1): 89-97, 1998.
7. Tang L, Jin T, Zeng X and Wang JS: Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J Nutr 135(2): 287-290, 2005.
8. Franceschi S, Bidoli E, La Vecchia C, Talamini R, D'Avanzo B and Negri E: Tomatoes and risk of digestive-tract cancers. Int J Cancer 59(2): 181-184, 1994.
9. Erhardt JG, Meisner C, Bode JC and Bode C: Lycopene, betacarotene, and colorectal adenomas. Am J Clin Nutr 78(6): 1219-1224, 2003.
10. Guttenplan JB, Chen M, Kosinska W, Thompson S, Zhao Z and Cohen LA: Effects of a lycopene-rich diet on spontaneous and benzo(a)pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett 164(1): 1-6, 2001.
11. Verhoeven DTH, Assen N, Goldbohm RA, Dorant E, Van't Veer P, Sturmans F, Hermus RJJ and Van den Brandt PA: Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: A prospective cohort study. Br J Cancer 75(1): 149-155, 1997.
12. Jenab M, Riboli E, Ferrari P, Friesen M, Sabate J, Norat T, Slimani N, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Boeing H, Schulz M, Linseisen J, Nagel G, Trichopoulou A, Naska A, Oikonomou E, Berrino F, Panico S, Palli D, Sacerdote C, Tumino R, Peeters PH, Numans ME, Bueno-de-Mesquita HB, Büchner FL, Lund E, Pera G, Chirlaque MD, Sánchez MJ, Arriola L, Barricarte A, Quirós JR, Johansson I, Johansson A, Berglund G, Bingham S, Khaw KT, Allen N, Key T, Carneiro F, Save V, Del Giudice G, Plebani M, Kaaks R and Gonzalez CA: Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. Br J Cancer 95(3): 406-415, 2006.
13. Persson C, Sasazuki S, Inoue M, Kurahashi N, Iwasaki M, Miura T and for the JPHC Study Group: Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: A nested case-control study. Carcinogenesis 29(5): 1042-1048, 2008.
14. Mukherjee B, Ghosh MK and Hossain CM: Anticancer potential of vitamin A and beta-carotene: mechanistic approach. NSHM J Pharm Healthcare Manag 2(2): 1-12, 2011.
15. Palozza P, Serini S, Maggiano N, Angelini M, Boninsegna A, Nicuolo F, Ranelletti FO and Calviello G: Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by β-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23(1): 11-18, 2002.
16. Williams AW, Boileau TW, Zhou JR, Clinton SK and Erdman JW Jr.: Beta-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. J Nutrition 130(4): 728-732, 2000.
17. Hazuka MB, Edwards-Prasad J, Newman F, Kinzie JJ and Prasad KN: Beta-carotene induces morphological differentiation and decreases adenylate cyclase activity in melanoma cell culture. J Am Coll Nutr 9(2): 143-149, 1990.
18. Hwang ES and Bowen PE: Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 7(3): 284-289, 2004.
19. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J and Sharoni Y: Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36(1): 101-111, 2000.
20. Burgess LC, Rice E, Fischer T, Seekins JR, Burgess TP, Sticka SJ and Klatt K: Lycopene has limited effect on cell proliferation in only two of seven human cell lines (both cancerous and noncancerous) in an in vitro system with doses across the physiological range. Toxicol In Vitro 22(5): 1297-1300, 2008.
21. Teodoro AJ, Oliveira FL, Martins NB, Maia Gde A, Martucci RB, Borojevic R.: Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell International 12(1): 362-369, 2012.
22. Diehl JA: Cycling to cancer with cyclin D1. Cancer Biol Ther 1(3): 226-231, 2003.
23. McClain M and Bausch J: Summary of safety studies conducted with synthetic lycopene. Regul Toxicol Pharmacol 37(2): 274-285, 2003.
24. Pool-Zobel BL, Bub A, Muller H, Wollowski I and Rechkemmer G: Consumption of vegetables reduces genetic damage in humans: first result of a human intervention trial with carotenoid-rich foods. Carcinogenesis 18(9): 1847-1850, 1997.
25. Shahrzad S, Cadenas E, Sevanian A and Packer L: Impact of water-dispersible beadlets as a vehicle for the delivery of carotenoids to cultured cells. Biofactors 16(3-4): 83-91, 2002.
26. Teodoro AJ, Oliveira FL, Soares NCP,Gloria NF, Martucci RB and Borojevic R: Efeito do licopeno na proliferação, ciclo celular e apoptose em linhagem celular de adenocarcinoma de mama humano. RSBC 11(6): 6-12, 2011.
27. Chalabi N, Le Corre L, Maurizis JC, Bignon YJ and Bernard-Gallon DJ: The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. European J Cancer 40(11): 1768-1775, 2004.
28. Prakash P, Russel RM and Krinsky NI: In vitro inhibition of proliferation of strogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids. Nutr Cancer 131(5): 1574-1580, 2001.
29. Bana E and Bagrel D: In Vitro Breast Cancer Models as Useful Tools in Therapeutics? Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis. Prof. Mehmet Gunduz and Esra Gunduz (Ed.), ISBN 978-953-307-766-6. 2011.
30. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res and Treat 83(3): 249-289, 2004.
31. Uppala PT, Dissmore T, Lau BHS, Andacht T and Rajaram S: Selective Inhibition of Cell Proliferation by Lycopene in MCF- 7 Breast Cancer Cells In vitro: A Proteomic Analysis. Phytother Res 27(4): 595-601, 2013.
32. Obermüller-Jevic UC, Olano-Martin E, Corbacho AM, Eiserich JP, Van der Vliet A, Valacchi G, Cross CE and Packer L: Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 133(11): 3356-3360, 2003.
33. Palozza P, Serini S, Boninsegna A, Bellovini D, Lucarini M, Monastra G and Gaetani S: The growth-inhibitory effects of tomatoes digested in nitro in colon adenocarcinomacells occur through down-regulation of cyclin D1, Bcl-2 and Bcl-XL. Br J Nutr 98(4): 789-795, 2007.
34. Haddad NF, Teodoro AJ, Leite de Oliveira F, Soares N, de Mattos RM, Hecht F, Dezonne RS, Vairo L, Goldenberg RC, Gomes FC, de Carvalho DP, Gadelha MR, Nasciutti LE and Miranda-Alves L: Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells. Plos One 8(5): 1-12, 2013.
35. Teodoro AJ, Perrone D, Martucci RB and Borojevic R: Lycopene isomerisation and storage in vitro model of murine hepatic stellate cells. Eur J Nutr 48(5): 261-268, 2009.
36. Martucci RB, Ziulkoski AL, Fortuna VA, Guaragna RM, Guma FC, Trugo LC and Borojevic R: Beta-carotene storage, conversion to retinoic acid, and induction of the lipocyte phenotype in hepatic stellate cells. J Cell Biochem 92(2): 414-423, 2004.
37. Muller K, Carpenter KL, Challis IR, Skepper JN and Arends MJ: Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic Res 36(7): 791-802, 2002.
38. Heber D and Qing-Yi Lu: Overview of Mechanisms of Action of Lycopene. Experimental Bio and Med 227(10): 920-923, 2002.
39. Kerr JFR, Winterford CM and Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73(8): 2013-2026, 1994.
40. Salman H, Bergman M, Djaldetti M and Bessler H: Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed Pharmacotherapy Vol: 61, 2007.
41. Heber D and Qing-Yi Lu: Overview of Mechanisms of Action of Lycopene. Experimental Bio and Med 61(6): 366-369, 2002.
42. Tsu-Tuan Wu, Kuo-Chen Wang and Guey-Mei Jow: Antiproliferative Effects of Lycopene and B-Cryptoxanthin on Human Lung Adenocarcinoma A549 Cells. FJJM 8(2): 67-75, 2010.
43. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES and Cox ME: Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 26(2): 252-263, 2007.
44. Jang SH, Lim JW and Kim H: Mechanism of beta-caroteneinduced apoptosis of gastric cancer cells: involvement of ataxiatelangiectasia- mutated. Ann NY Acad Sci 1171: 156-62, 2009.
45. Li Z, Hu CY, Mo BQ, XU JD and Zhao Y: Effect of betacarotene on gene expression of breast cancer cells. Ai Zheng. 22(4): 380-384, 2003.